Bellerophon Therapeutics, Inc. (BLPH)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 661.79k |
| Enterprise Value | -14.50M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.11 |
| Price/Book (mrq) | 0.18 |
| Enterprise Value/Revenue | -2.57 |
| Enterprise Value/EBITDA | 1.31 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.68 |
| 52-Week Change 3 | -99.29% |
| S&P500 52-Week Change 3 | 22.64% |
| 52 Week High 3 | 11.1500 |
| 52 Week Low 3 | 0.0290 |
| 50-Day Moving Average 3 | 0.0544 |
| 200-Day Moving Average 3 | 0.1653 |
Share Statistics
| Avg Vol (3 month) 3 | 43.4k |
| Avg Vol (10 day) 3 | 15.08k |
| Shares Outstanding 5 | 12.23M |
| Implied Shares Outstanding 6 | 13.25M |
| Float 8 | 10.2M |
| % Held by Insiders 1 | 15.03% |
| % Held by Institutions 1 | 10.39% |
| Shares Short (Sept 29, 2023) 4 | 90.45k |
| Short Ratio (Sept 29, 2023) 4 | 1.26 |
| Short % of Float (Sept 29, 2023) 4 | 0.90% |
| Short % of Shares Outstanding (Sept 29, 2023) 4 | 0.74% |
| Shares Short (prior month Aug 31, 2023) 4 | 123.63k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Feb 10, 2020 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:15 |
| Last Split Date 3 | Feb 10, 2020 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2022 |
| Most Recent Quarter (mrq) | Sept 30, 2023 |
Profitability
| Profit Margin | -164.06% |
| Operating Margin (ttm) | -195.76% |
Management Effectiveness
| Return on Assets (ttm) | -78.47% |
| Return on Equity (ttm) | -165.96% |
Income Statement
| Revenue (ttm) | 5.64M |
| Revenue Per Share (ttm) | 0.51 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -11.04M |
| Net Income Avi to Common (ttm) | -9.25M |
| Diluted EPS (ttm) | -0.8900 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.38M |
| Total Cash Per Share (mrq) | 0.36 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.96 |
| Book Value Per Share (mrq) | 0.30 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12.34M |
| Levered Free Cash Flow (ttm) | -9.7M |
© 2024 Yahoo. All rights reserved.